Glow-in-the-dark dye could help surgeons spot hidden cancer during head and neck surgery
NCT ID NCT07149207
First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times
Summary
This study tests whether a dye called ICG can help surgeons see tumor tissue more clearly during head and neck cancer surgery. About 30 adults with squamous cell carcinoma who are at risk of recurrence will receive the dye before surgery, and doctors will use a special camera to look for glowing tissue. The goal is to improve how well surgeons can tell cancer from healthy tissue, which may lead to more complete tumor removal. Participation lasts about 6 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARGIN ASSESSMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of South Carolina Hollings Cancer Center
RECRUITINGCharleston, South Carolina, 29425, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study: can early palliative care help head and neck cancer patients suffer less?
- AI reads social media posts to spot suicide risk in skin cancer patients
- Could a 3-Week radiation course replace 6 weeks for head and neck cancer?
- Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
- Light-Based scanner could help surgeons remove all cancer in one go
- New drug combo aims to outperform keytruda in head and neck cancer